Donepezil (Aricept) Dose Titration Protocol
The recommended dose titration for donepezil (Aricept) begins with 5 mg once daily in the evening for 4-6 weeks, then increasing to 10 mg once daily if well tolerated, with a potential increase to 23 mg daily after at least 3 months on 10 mg for patients with moderate to severe Alzheimer's disease. 1
Initial Dosing and Titration Schedule
Mild to Moderate Alzheimer's Disease
- Starting dose: 5 mg once daily in the evening, just prior to retiring
- Titration: After 4-6 weeks on 5 mg daily, may increase to 10 mg daily if well tolerated
- Maximum dose: 10 mg once daily 1
Moderate to Severe Alzheimer's Disease
- Starting dose: Same as above (5 mg once daily)
- First titration: After 4-6 weeks on 5 mg daily, may increase to 10 mg daily
- Second titration: After at least 3 months on 10 mg daily, may increase to 23 mg daily
- Maximum dose: 23 mg once daily 1
Administration Guidelines
- Take in the evening, just prior to retiring
- Can be taken with or without food
- The 5 mg and 10 mg tablets can be split if needed
- The 23 mg tablet should NOT be split, crushed, or chewed 1
Monitoring and Dose Adjustments
Efficacy Assessment
- Evaluate beneficial response after 6-12 months of treatment 2
- Consider discontinuation if:
- Side effects develop and don't resolve
- Continued deterioration at pre-treatment rate after 6-12 months
Special Populations
- Hepatic impairment:
- Renal impairment: No specific dose adjustments required in the FDA labeling
Side Effect Management
Common Side Effects
- Gastrointestinal: nausea, vomiting, diarrhea (more common with 10 mg than 5 mg, and more common with 23 mg than 10 mg) 1
- Neurological: dizziness, headache, insomnia 3
Minimizing Side Effects
- The 6-week titration period (rather than faster titration) helps minimize cholinergic side effects 3
- Taking the medication in the evening may reduce the impact of side effects
- If side effects are problematic at 10 mg, consider returning to 5 mg dose
Clinical Pearls
- Donepezil provides modest but significant benefits in cognitive function, with improvements of 1.9-2.9 points on the ADAS-Cog scale at 24 weeks compared to placebo 2
- Benefits include improved cognition, global clinical function, activities of daily living, and behavioral symptoms 4
- The long half-life (approximately 70 hours) allows for once-daily dosing 5
- Unlike tacrine, donepezil does not require liver function monitoring as it has not shown evidence of hepatotoxicity 3
Common Pitfalls to Avoid
- Titrating too quickly: Increasing the dose before the recommended 4-6 week period can lead to increased cholinergic side effects
- Missing the opportunity for dose escalation: Some patients may benefit from the higher 10 mg dose but are never titrated up from 5 mg
- Inappropriate use of 23 mg dose: The 23 mg dose should only be used after at least 3 months on 10 mg and only for moderate to severe Alzheimer's disease
- Splitting the 23 mg tablet: This tablet has special formulation and should never be split, crushed, or chewed
Donepezil remains a first-line treatment for Alzheimer's disease with a well-established efficacy and safety profile when properly titrated according to this protocol.